Securities Code: 002382 Bond Code: 128108 Securities Abbreviation: Blue Sail Medical Bond Abbreviation: Blue Sail Convertible Announcement No.: 2026-040
Blue Sail Medical Co., Ltd. Announcement on the Proposed Non-Distribution of Profits for 2025
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.
Special Reminder:
- The Company's profit distribution proposal for 2025 is: no cash dividend, no bonus shares, and no capital reserve to increase share capital.
- The Company's profit distribution proposal for 2025 does not involve any circumstances that may lead to other risk warnings as stipulated in Article 9.8.1 of the "Shenzhen Stock Exchange Stock Listing Rules" (hereinafter referred to as the "Listing Rules").
I. Deliberation Procedures Blue Sail Medical Co., Ltd. (hereinafter referred to as the "Company") held the 42nd meeting of the Sixth Board of Directors on April 27, 2026, which reviewed and approved the "Proposal on the Company's 2025 Profit Distribution Plan". It was agreed that the Company would not distribute cash dividends, issue bonus shares, or convert capital reserves into share capital in 2025. This proposal needs to be submitted to the Company's 2025 Annual General Meeting for deliberation.
II. Basic Situation of Profit Distribution and Capital Reserve to Increase Share Capital Plan According to the standard unqualified audit report issued by EY Hua Ming Certified Public Accountants (Special General Partnership) (EY Hua Ming (2026) Audit No. 70038396 X01), the net profit realized by the parent company in 2025 was -23,897.11 million yuan. Adding the undistributed profit at the beginning of the year of -16,313.84 million yuan, subtracting the statutory surplus reserve of 0 yuan for the year, and subtracting the profit distribution of 0 yuan in 2024, the actual profit available for distribution to shareholders in 2025 was -40,210.94 million yuan. In 2025, the net profit attributable to shareholders of the listed company was -75,894.08 million yuan, and the consolidated profit available for distribution was 84,919.70 million yuan.